Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?
about
Society of Gynecologic Oncology recommendations for the prevention of ovarian cancerRationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the EvidencePathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.Analysis of serial ovarian volume measurements and incidence of ovarian cancer: implications for pathogenesis.In their own words: treating very young BRCA1/2 mutation-positive women with care and caution.The new face of ovarian cancer modeling: better prospects for detection and treatment.The fallopian tube: from back stage to center stage.Clinical Considerations of BRCA1- and BRCA2-Mutation Carriers: A Review.Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study.Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act.Fallopian Tube Ligation or Salpingectomy as Means for Reducing Risk of Ovarian Cancer.Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers.Fallopian tube removal: "stic-ing" it to ovarian cancer: what is the utility of prophylactic tubal removal?Examining the use of salpingectomy with hysterectomy in Canada.Salpingectomy as standard at hysterectomy? A Danish cohort study, 1977-2010.Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers.BRCA carriers, prophylactic salpingo-oophorectomy and menopause: clinical management considerations and recommendations.Hereditary cancer syndromes with high risk of endometrial and ovarian cancer: surgical options for personalized care.Opportunistic Salpingectomy as an Ovarian Cancer Primary Prevention Strategy.Primary culture and immortalization of human fallopian tube secretory epithelial cells.Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK.Ovarian Cancer Prevention in High-risk Women.The 'incessant menstruation' hypothesis: a mechanistic ovarian cancer model with implications for prevention.A patient decision aid for risk-reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing.Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study.Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated Decision.Prophylactic salpingectomy and ovarian cancer: An evidence-based analysis.
P2860
Q27009306-93BDBF81-C6BC-4817-B0F2-6C8B34731551Q30250107-A1E2AE59-DD97-4C5B-A7FA-331375E3792CQ30370475-843D1661-AD85-4E85-855E-8E4C43248CDAQ34209092-A5AEE5A6-FDD2-4783-B1F2-B6B1B96956E4Q35105959-848C2E65-90A1-4A40-B247-EC6F8F66B488Q35507860-71A1C877-EA98-4DC3-BE4B-BBDA6E743A5DQ35562911-AA83537B-7DFF-4AE8-8262-505DAD6C196AQ35687632-30B0469A-8904-4CA7-97CE-006EE5CD6B2EQ35749439-A0B8576A-C017-4C2E-A181-1AAC43C65AC9Q36313479-6DD3FA5A-5464-493B-995A-D79927B28305Q36342787-92D7A781-6CB0-430C-9914-F822A200675CQ36634141-DD9AF7A5-A39A-4A67-A15D-A8D25E724D02Q36897742-6AD66A20-B5C4-4B23-8B2F-BB8872BF34D2Q36897769-BEFEA3E6-EEFB-4B6A-AE7A-7866D9AB9CBFQ36939176-3C131173-043A-45B3-8E20-1DE46571CBBAQ37512375-05235FC0-C0D8-4E48-B058-2F91C3918A81Q38039167-C55BDC22-6462-42B4-BEF8-18200EED6CD4Q38241489-C0418235-2FE4-4FAA-8C6B-0CD8D9B05AC7Q38657938-437A7C01-5918-43C7-8317-52B8E68317E8Q39287947-4DB463F7-3A5B-4835-92F0-FCD17248578DQ40732955-69412032-A94F-43D9-B18C-85699EF72117Q45068704-FF208063-4FB8-4352-8F06-D6BE9441C376Q45792166-810C2D13-B542-4CC7-B255-C8E6FA1A5493Q47762116-AF2F5E8D-DE99-4B1C-ABAA-B0F80012CD9CQ52724999-1AF2C3DA-C389-4E7C-AF6E-293B5DFFA61BQ54956851-EFC4E974-DCF3-4B80-BD50-703FEDC0AE3AQ55120351-983A2A18-4114-4DC7-B407-A83FCF85C792
P2860
Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Does bilateral salpingectomy w ...... in BRCA1/2 mutation carriers?
@ast
Does bilateral salpingectomy w ...... in BRCA1/2 mutation carriers?
@en
Does bilateral salpingectomy w ...... in BRCA1/2 mutation carriers?
@nl
type
label
Does bilateral salpingectomy w ...... in BRCA1/2 mutation carriers?
@ast
Does bilateral salpingectomy w ...... in BRCA1/2 mutation carriers?
@en
Does bilateral salpingectomy w ...... in BRCA1/2 mutation carriers?
@nl
prefLabel
Does bilateral salpingectomy w ...... in BRCA1/2 mutation carriers?
@ast
Does bilateral salpingectomy w ...... in BRCA1/2 mutation carriers?
@en
Does bilateral salpingectomy w ...... in BRCA1/2 mutation carriers?
@nl
P2093
P2860
P1476
Does bilateral salpingectomy w ...... in BRCA1/2 mutation carriers?
@en
P2093
Mark H Greene
Peter E Schwartz
Phuong L Mai
P2860
P304
P356
10.1016/J.AJOG.2010.05.038
P407
P577
2010-07-08T00:00:00Z